Noncoding variants in the human MIR137 gene locus increase schizophrenia risk with genome-wide significance. However, the functional consequence of these risk alleles is unknown. Here we examined induced human neurons harboring the minor alleles of four disease-associated single nucleotide polymorphisms in MIR137. We observed increased MIR137 levels compared to those in major allele-carrying cells. microRNA-137 gain of function caused downregulation of the presynaptic target genes complexin-1 (Cplx1), Nsf and synaptotagmin-1 (Syt1), leading to impaired vesicle release. In vivo, miR-137 gain of function resulted in changes in synaptic vesicle pool distribution, impaired induction of mossy fiber long-term potentiation and deficits in hippocampus-dependent learning and memory. By sequestering endogenous miR-137, we were able to ameliorate the synaptic phenotypes. Moreover, reinstatement of Syt1 expression partially restored synaptic plasticity, demonstrating the importance of Syt1 as a miR-137 target. Our data provide new insight into the mechanism by which miR-137 dysregulation can impair synaptic plasticity in the hippocampus. 
a r t I C l e S
The underlying cause of neuropsychiatric disorders is suspected to be a combination of genetic predisposition and environmental factors. Genome-wide association studies have reported single nucleotide polymorphisms (SNPs) in the human miR-137 gene locus that are associated with an increased risk of schizophrenia and autism spectrum disorders 1, 2 . MicroRNAs in general have the potential to modulate hundreds of messenger RNAs simultaneously by regulating mRNA translation 3 . They bind to a 6-to 8-base-pair complementary 'seed region' typically located in the 3′ UTR of the target mRNA. This interaction either facilitates the degradation of the mRNA or delays its translation 4 . Even a modest dysregulation of microRNA levels may cause cellular malfunction and could lead to disease phenotypes 5 .
miR-137 is enriched in the dentate gyrus, a subregion of the hippocampal formation 6, 7 . The axonal processes of the dentate granule neurons, the mossy fibers, transmit information encoding facets of learning and memory to the proximal dendrites of pyramidal neurons in the CA3 region of the hippocampus 8 . While previous studies have demonstrated that miR-137 regulates dendritic development both in vitro and in vivo in adult granule neurons 7, 9 , the function of miR-137 in the presynaptic compartment remains unexplored. It is crucial to elucidate the functional consequences of gene variants associated with psychiatric disorders, as cognitive and synaptic dysfunctions are phenotypes common to schizophrenia and autism spectrum disorders 10, 11 .
Here we show that miR-137 gain of function downregulates, in vitro and in vivo, three presynaptic target genes, causing impairment in synaptic vesicle trafficking and alterations in synaptic plasticity.
Overall, we describe a new mechanism of synaptic modulation that may be perturbed in disorders such as schizophrenia.
RESULTS

Increased MIR137 in neurons harboring minor allele SNPs
The schizophrenia-associated SNPs (rs1198588, rs1625579, rs2660304 and rs2802535) at the MIR137 gene locus are positioned in the noncoding region (Fig. 1a) . SNP rs2660304 is located only 400 base pairs upstream of the primary transcript sequence of MIR137. Variations in this region can result in defective mRNA splicing, stability and structure 12 . We observed transcriptional activity, indicated by increased luciferase expression, for the genomic fragments around SNPs rs1198588 and rs2660304 (Supplementary Fig. 1 ).
SNPs are categorized as major and minor alleles depending on the frequency of their occurrence in a given human population. To access consequences of the SNP genotype in human neurons, we obtained six human fibroblast lines that were homozygous either for the common, major allele or for the rare, minor allele for all four SNPs (Supplementary Fig. 1 ). We directly converted fibroblasts to neurons by transducing each line with the transcription factors ASCL1, BRN2 or MYT1L (Fig. 1b) 13 . After 4 weeks, we transduced the neuron-like cells with herpes simplex virus (HSV) expressing the fluorescent protein mCherry under the CAMK2A (calcium/calmodulin-dependent protein kinase II-α) promoter to confirm their neuronal identity and to allow isolation of these cells from un-reprogrammed fibroblasts (Supplementary Fig. 1 ).
We observed a significant increase of endogenous MIR137 levels in the minor compared to the major allele SNP group (Fig. 1c) .
This difference was detected only in induced neurons and not in fibroblasts. As an additional control, we measured the expression levels of miR-9, miR-19b and miR-124, which are commonly described as part of the neuronal miRNA signature 14 . We did not observe any difference in the levels between minor and the major allele SNP group (Supplementary Fig. 1 Gray and dark orange, deleted miR-137-binding site. Syn3 has two predicted miR-137-binding sites, s1 and s2. t psiCheck2 (53.51) = 0.40, ns P = 0.6932, r = 0.06; t Ezh2 (40.7) = −8.94, ***P < 0.001, r = 0.81; F Cplx1 (3,74) = 6.73, ***P < 0.001; F Nsf (3,54) = 97.32, ***P < 0.001; F Syn3-s1 (3,75) = 16.67, ***P < 0.001; F Syn3-s2 (3,108) = 8.47, ***P < 0.001; F Syt1 (3,181) = 67.12, ***P < 0.001; F Hcrt (3,85) = 14.12, ***P < 0.001; F Syt7 (3,74) = 37.38, ***P < 0.001; F Stx17 (3,80) = 3.44, *P = 0.0207; post hoc pairwise comparison of ∆miR-137 OE and miR-137 OE after Benjamini and Hochberg adjustment for multiple comparisons: Cplx1, P = 0.0006; Nsf, P < 0.001; Syn3-s1, P < 0.001; Syn3-s2, P = 0.00016; Syt1, P < 0.001; Hcrt, P = 0.0029; Syt7, P < 0.001; Stx17, P = 0.043; n (given in each bar), number of experiments, each in triplicate. (f,g) mRNA levels of miR-137 target genes in HT22 (f) and N2a (g) cells transfected with a commercially available miR-137 mimic normalized to a mimic-control. HT22: t Cplx1 (6.98) = −3.58, **P = 0.0090, r = 0.81; W Nsf = 0, **P = 0.0022, r = −0.89; t Syn3 (9.71) = −3.40, **P = 0.007, r = 0.74; t Syt1 (3.21) = −2.99, ns P = 0.0535, r = 0.86; W Hcrt = 15, ns P = 0.4452, r = −0.21; t Syt7 (6.06) = −1.02, ns P = 0.3481, r = 0.38; t Stx17 (4.31) = 0.51, ns P = 0.6337, r = 0.24; N2a: t Cplx1 (9.10) = −6.18, ***P < 0.001, r = 0.90; t Nsf (4.43) = −3.01, *P = 0.3453, r = 0.82; t Syn3 (8.99) = −6.23, ***P < 0.001, r = 0.90; W Syt1 = 0, *P = 0.0286, r = −0.77; t Hcrt (10) = −3.15, *P = 0.0103, r = −0.71; t Syt7 (6.27) = 0.91, ns P = 0.3962, r = 0.34; t Stx17 (9.96) = −2.47, *P = 0.033, r = 0.62; n, number of experiments. (h) mRNA levels in induced neurons by qRT-PCR. t CPLX1 (5.97) = 2.56, *P = 0.043, r = 0.72; t NSF (17.89) = 2.85, *P = 0.0107, r = 0.56; t SYN3 (11.29) = 3.00, *P = 0.0118, r = 0.67; t SYT1 (13.40) = 3.45, **P = 0.004, r = 0.69; t PCLO (22.95) = 1.05, ns P = 0.3034, r = 0.22; t STX8 (20.36) = −0.49, ns P = 0.7013, r = 0.22; t SYNJ1 (18.94) = −1.21, ns P = 0.2398, r = 0.27; n, number of samples from at least three reprogrammings of each fibroblast line. (i) FM4-64 imaging analysis. H(1) = 38.15, ***P < 0.001; n, number of analyzed cells, usually one cell per coverslip from two reprogramming from each fibroblast line. ns, not significant. Error bars, s.e.m., W, Wilcoxon rank-sum and signed-rank tests; r, effect size; H, Kruskal-Wallis rank-sum test. a r t I C l e S miR-137 targets presynaptic proteins miR-137 has been shown to affect dendritic development 7, 9 . However, when we performed an in silico screen for predicted miR-137 targets, we found at least 21 genes with well-known roles in presynaptic vesicle trafficking (Supplementary Fig. 2 ). Since a presynaptic role of microRNAs has not been described so far, we were interested whether miR-137 could influence presynaptic plasticity.
To validate the targets, we cloned the 3′ UTR of each gene of interest downstream of a Renilla luciferase gene and upstream of a polyadenylation site (Fig. 1d) . In addition, we deleted the miR-137 target site in the 3′ UTR to confirm miR-137-specific interaction with the predicted binding site (∆ constructs). We then transfected human embryonic kidney (HEK)-293T cells with the luciferase construct together with constructs overexpressing miR-137 (miR-137 OE ) or the control construct miR-CNTL as previously reported 15 . The empty psiCheck2 vector and the 3′ UTR of Ezh2 served as negative and positive controls, respectively 9 . For 7 of the 21 putative target genes, we observed a significant downregulation in the presence of miR-137 OE but not ∆miR-137 OE or 3′ UTR-∆ constructs ( Fig. 1e and Supplementary  Fig. 2 ). Among these genes were ones encoding well-known presynaptic proteins such as complexin-1 (Cplx1), N-ethylmaleimidesensitive fusion protein (Nsf) and synaptotagmin-1 (Syt1). To assess the action of miR-137 on the potential target genes in a neuronal context, we transfected HT22 and N2a neuroblastoma cell lines with miR-137 mimic, a chemically modified, commercially available double-stranded RNA that mimics endogenous miRNA upregulation.
After 48 h, we found that endogenous Cplx1, Nsf, Syn3 and Syt1 mRNAs were each downregulated upon expression of miR-137 mimic in both cell lines (Fig. 1f,g ). Hcrt, Syt7 and Stx17, however, showed inconsistent downregulation between the N2a and HT22 neural cell lines upon expression of miR-137 mimic and were therefore excluded from further validation.
We then asked whether we could observe a similar downregulation in CPLX1, NSF, SYN3 and SYT1 mRNAs in the induced human neurons showing MIR137 gain of function. Consistent with the increased levels of endogenous MIR137, we saw a marked decrease of endogenous mRNA levels for all four target genes in the minor allele SNP group (Fig. 1h) . We also measured the mRNA levels of presynaptic genes whose expression should not be affected by MIR137, such as Piccolo (PCLO), or that were negative in our luciferase assay (synaptojanin 1 (SYNJ1), syntaxin 8 (STX8)). As expected, levels of these mRNAs did not differ between both groups.
Finally, we were interested whether miR-137 gain of function would have a direct effect on vesicle trafficking in induced neurons. To test this, we monitored functional nerve terminals using the dye FM4-64 in the presence of KCl-mediated neuronal excitation (Supplementary Fig. 2 ). We observed that the FM4-64 depleted more slowly in induced neuron of the minor allele SNP group than those of the major allele SNP group (Fig. 1i) . Taken together, these data provide evidence that miR-137 targets the mRNAs for Cplx1, Nsf, Syn3 and Syt1-presynaptic proteins implicated in vesicle trafficking and synaptic transmission. , showing mCherry (magenta), the mossy fiber marker zinc transporter 3 (ZnT3, green) and the nuclear dye DAPI (blue). DG, dentate gyrus. Representative images from at least three animals. Scale bars, 100 µm. (d) miR-137 expression in ∆miR-137 OE -injected, miR-137 OE -injected and naive animals. H(2) = 7.68, *P = 0.0215, post hoc pairwise comparison after Tukey test (t ∆miR-137 OE -miR-137 OE = 2.53, *P = 0.0471; t miR-137 OE -naive = −2.72, *P = 0.0312; t ∆miR-137 OE -naive = 0.261, ns P = 0.796); box plot shows, in ascending order, lowest maximum value, first quartile, median, third quartile and highest maximum value, with dots representing outliers; n, number of dissected dorsal DG regions from at least three animals. (e) Quantification of proteins for miR-137 target genes in the mossy fiber-CA3 pathway for ∆miR-137 OE and miR-137 OE ; t Cplx1 (5.43) = −6.46, ***P < 0.01, r = 0.94; t Nsf (6.47) = −3.43, *P = 0.0123, r = 0.80; t Syn3 (9.89) = −3.00, *P = 0.0135, r = 0.69; t Syt1 (7.21) = −2.47, *P = 0.0418, r = 0.68; n, dorsal DG-CA3 region of at least three animals. Right, cropped western blot images. Full-length blots are presented in Supplementary Figure 9 . ns, not significant. Error bars, s.e.m. npg a r t I C l e S Overexpression of miR-137 in vivo in the dentate gyrus Next we tested the consequences of miR-137 gain of function in vivo.
To do this, we created a miR-137 overexpression construct in a lentiviral vector backbone (miR-137 OE ), which allows the long-term overexpression of miR-137 in adult mice. We designed the construct to contain the presumptive pri-miRNA-137, which includes 500 base pairs flanking the miR-137 coding sequence (Fig. 2a) . This approach was aimed at preserving in vivo processing mechanisms, in which primiRNA-137 is bound by Drosha and Dicer and then processed to the 20-nt mature miRNA-137. For the control construct, we deleted the mature miR-137 sequence (∆miR-137 OE ). To provide visual confirmation of virus transduction, the miR-137 OE and ∆miR-137 OE constructs also expressed mCherry under the control of the ubiquitin promoter. We confirmed miR-137 overexpression in transduced HEK-293T cells and in primary cortical neurons (Supplementary Fig. 3 ).
Structural and functional abnormalities in the hippocampus have been implicated in schizophrenia and autism phenotypes 10, 16 . miR-137 has been shown to be strongly expressed in the dentate gyrus 6, 7 , and therefore we decided to assess miR-137 gain of function in the dorsal dentate gyrus (Fig. 2b) . We successfully targeted the dorsal dentate gyrus of 8-week-old male C57BL/6 wild-type mice and found coexpression of the mCherry signal with immunoreactivity for the mossy fiber marker ZnT3 (ref. 17) (Fig. 2c and Supplementary Fig. 3 ). mCherry expression was not observed in astrocytes or microglia (Supplementary Fig. 3 ). Using quantitative real-time-PCR (qRT-PCR), we found that miR-137 levels were increased approximately twofold in miR-137 OE mice as compared to the endogenous levels measured in naive and ∆miR-137 OE -injected animals (Fig. 2d) .
To confirm that miR-137 gain of function affects presynaptic targets in vivo, we dissected mCherry-positive dentate gyrus-CA3 under an epifluorescence stereomicroscope and performed synaptosomal fractioning to enrich for synaptic proteins. All four targets showed significantly reduced protein expression in the presence of miR-137 OE as compared to ∆miR-137 OE (Fig. 2e) suggesting that we were able to recapitulate the in vitro phenotype in vivo.
Vesicle trafficking is altered in miR-137 OE mice miR-137 gain of function appears to affect vesicle release in human induced neurons (Fig. 1i) . Since we confirmed the miR-137 OE -mediated reduction of four key presynaptic proteins in vivo, we used electron microscopy at the mossy fiber synapse to explore whether miR-137 OE alters in vivo synaptic vesicle distribution. We observed a notably vesicle-sparse region in the mossy fiber presynaptic terminals in the miR-137 OE mice but not in control ∆miR-137 OE animals ( Fig. 3a and Supplementary Fig. 4 ). When we quantified the number of vesicles at increasing distance from the active zone, we found a significant reduction in the vesicle number at a distance of 50-200 nm from the release site in miR-137 OE synapses as compared to controls (Fig. 3b) . This was accompanied by increased vesicle numbers at 350-450 nm from the active release site in miR-137 OE synapses. We did not find a difference in the overall number of vesicles across the two conditions ( Supplementary Fig. 4) .
To determine the functional impact of these structural presynaptic abnormalities at the miR-137 OE mossy fiber synapse, we performed frequency facilitation measurements in acute hippocampal slices. We applied sustained low-frequency stimulation to dentate granule cells and recorded responses from mossy fiber synapses in CA3 (Fig. 3c) . In the control ∆miR-137 OE slices, we observed a marked increase in the amplitude of synaptic responses evoked at the mossy fiber-CA3 synapse, which stabilized around 300% and persisted until the stimulation finished (Fig. 3d) . In contrast, the amplitude of the response reached a lower plateau in miR-137 OE slices. This suggests that miR-137 alters presynaptic function at the mossy fiber synapse in dentate granule cells.
miR-137 gain of function affects LTP and learning behavior
To further explore the mechanism of miR-137 gain of function in vivo in the hippocampus, we investigated mossy fiber LTP in acute hippocampal slices prepared from miR-137 OE and ∆miR-137 OE mice. In this protocol, we placed the stimulating electrode in the granule neuron layer in the dentate gyrus and recorded from the mossy fibers in the CA3 region (Fig. 3c) . We found that high-frequency stimulation led to less mossy fiber LTP induction in slices from miR-137 OE mice, in contrast to those from ∆miR-137 OE animals (Fig. 4a) . To confirm that the recorded response was mediated by mossy fibers, we applied the group II metabotropic glutamate receptor agonist DCG-IV after 60 min of recording 18 . Baseline synaptic transmission was not altered (Fig. 4b) . Thus, miR-137 gain of function in the dentate gyrus impaired synaptic plasticity at the mossy fiber synapse. npg a r t I C l e S Finally, we tested the performance of miR-137 OE mice in hippocampus-dependent behavior tasks. First we assessed locomotor activity and anxiety-like behaviors. We did not observe differences between miR-137 OE and ∆miR-137 OE animals either in the open-field protocol or in the light-dark box or elevated-plus maze ( Supplementary Fig. 5 ). Then we used a fear-conditioning protocol that measures memory formation following a foot shock and memory recall in response to a conditioned stimulus consisting of either the context or a cue (tone). We found significantly less context-associated freezing response in the miR-137 OE mice than in ∆miR-137 OE controls, indicating impaired hippocampus-dependent memory (Fig. 4c) . In the cued fear conditioning, we did not observe this difference, which is consistent with the expectations because cue-dependent learning is amygdala dependent ( Fig. 4d) 19 . The two groups of mice showed equal pain sensitivity and freezing response to the initial shock ( Supplementary Fig. 5 ).
To further assess hippocampus-dependent memory impairment in miR-137 OE mice, we used the Morris water maze test. During the training phase, the escape latency of the miR-137 OE mice diminished less over time than that of the control ∆miR-137 OE mice (Fig. 4e) . Both groups had similar swim velocity (Fig. 4f) . During the probe trial, miR-137 OE animals showed deficits in locating the target quadrant ( Fig. 4g ). An increased tendency to rely on a thigmotaxis-based strategy could prevent learning; however, we did not find differences in the percentage of trail time nor in the trail path between the two groups ( Supplementary Fig. 5 ).
As variants in MIR137 have been associated with autism spectrum disorders in humans 1, 20 , we also examined the social behavior of miR-137 OE and ∆miR-137 OE mice using a three-chamber social interaction test. Both groups showed a similar preference for exploring a new mouse as compared to a familiar mouse and a similar preference for spending more time with a mouse than with an empty cage ( Supplementary Fig. 5 ). Together our data suggest that miR-137 gain of function in the dentate gyrus impairs hippocampusdependent learning.
Impact of miR-137 sequestration
To validate the role of miR-137 in regulating presynaptic vesicle trafficking, we reduced endogenous miR-137 levels using a 'sponge' construct 21 . The construct contained multiple miR-137 target sites to which endogenous miR-137 can bind (Sponge miR-137 ). As control, we used an empty vector backbone expressing GFP only (Sponge Control ).
First we transfected N2a cells with Sponge miR-137 and measured the mRNA expression of Cplx1, Nsf, Syn3 and Syt1 using qRT-PCR. We found that Cplx1, Nsf and Syt1 mRNA levels increased in the presence of Sponge miR-137 (Fig. 5a) . Surprisingly, Syn3 mRNA levels decreased. Subsequently, we attempted to reverse the endogenous miR-137 gainof-function phenotype in the induced human neurons from the minor allele SNPs group by transducing those cells with the Sponge miR-137 . As in the N2a cells, we observed increased CPLX1, NSF and SYT1 mRNA expression in the presence of Sponge miR-137 , while SYN3 was reduced (Fig. 5b) . Next we transduced induced neurons carrying the minor allele SNPs with the Sponge miR-137 to test the impact on vesicle trafficking. We observed a more rapid depletion of FM4-64 dye following KCl stimulation in the presence of the Sponge miR-137 , suggesting a faster vesicle release (Fig. 5c) .
We proceeded to test whether Sponge miR-137 could reverse the previously observed miR-137 OE -dependent phenotypes in vivo. We found that the protein levels of Cplx1, Nsf and Syt1 were increased upon Sponge miR-137 injection (Fig. 5d) . Ultrastructural analysis showed that vesicle numbers were slightly increased at the vesicle docking and at 50 nm from the synaptic release site at the Sponge miR-137 mossy fiber synapse as compared to control (Fig. 5e,f and Supplementary  Fig. 6 ). The absolute vesicle number did not change in the presence of the Sponge miR-137 (Supplementary Fig. 6 ).
We then evaluated the functional impact of miR-137 sequestration on synaptic function in the mouse hippocampus by stimulating dentate gyrus granule cells and recording in the mossy fiber-CA3 region as described in Figure 3c . In contrast to the impaired frequency npg a r t I C l e S facilitation found at miR-137 OE mossy fiber synapses (Fig. 3d) , we observed a strong increase in the synaptic response amplitude evoked at the mossy fiber-CA3 synapse in the presence of the Sponge miR-137 construct as compared to controls (Fig. 5g) . This amplitude stabilized around 500%, compared to 300% for the Sponge Control . When we measured mossy fiber LTP induction, we found an enhanced induction in Sponge miR-137 as compared to controls (Fig. 5h) . This was not due to changes in baseline synaptic transmission (Supplementary Fig. 6 ).
Next we determined the behavioral outcome of endogenous miR-137 sequestration. In the open-field arena, the Sponge miR-137 mice did not show a difference in total distance the time spent moving (Supplementary Fig. 6 ), but they had a trend toward more time spent in the center. However, when we focused on hippocampus-dependent learning, we observed a trend toward improved associative learning in the contextual fear conditioning protocol in the Sponge miR-137 group as compared to the Sponge Control (Fig. 5i) . The freezing response to the tone in the cued condition, after context and before the tone, as well as nociception, did not differ between the two groups ( Fig. 5j and Supplementary Fig. 6 ). Taken together, our results suggest that the sequestration of miR-137 can significantly reverse impairments caused by miR-137 gain of function at the mossy fiber-CA3 synapse.
Syt1 restoration ameliorates miR-137 gain of function
To further explore whether miR-137-associated synaptic phenotypes can be ameliorated by the expression of a single target gene, we decided to express miR-137-resistant Syt1 cDNA in the presence npg a r t I C l e S of miR-137 OE . Syt1 is a well-known presynaptic protein located on the synaptic vesicle membrane. It has been shown to trigger calciumdependent synaptic vesicle release and to act in vesicle recycling [22] [23] [24] [25] [26] . Syt1 mRNA and protein were prominently expressed in the dentate gyrus and hippocampal CA3 area (Supplementary Fig. 7 ).
We generated a bicistronic lentiviral vector that expresses miR-137 OE followed by an ubiquitin promoter-driven mouse Syt1 cDNA and eYFP Venus protein (Fig. 6a) . We also included a bicistronic construct overexpressing Syt1 cDNA and ∆miR-137 OE . Upon ultrastructural analysis of miR-137 OE -Syt1-Venus, we observed an increase in vesicle numbers from 100-250 nm compared to miR-137 OE -Venus; this, however, did not reach control levels seen in ∆miR-137 OE -Venus (Fig. 6b,c and Supplementary Fig. 7 ). In the periphery of the vesicle pool (>350 nm), vesicle numbers were not restored in the miR-137 OE -Syt1-Venus-containing synapses as compared to miR-137 OE -Venus alone (Fig. 6c) . Overall, expression H(3) = 106.41, ***P < 0.001. Shown is multiple comparison two-tailed test after Kruskal-Wallis, *P < 0.05; n, number of analyzed hippocampal slices from at least three animals. (f) Input-output curve of fEPSP against fiber volley amplitude at the mossy fiber-CA3 synapse. H(3) = 3.85, ns P = 0.2776. Shaded area, 95% confidence interval; n gray = 15, n red = 15, n purple = 15, n green = 15); n, number of analyzed hippocampal slices from at least three animals. (g) Freezing percentage for contextual fear conditioning. F(3,34) = 4.53, **P = 0.0089; post hoc Tukey analysis: t miR-137-miR137-Syt1 = 3.57, **P = 0.0060; t ∆miR-137-miR137 = −2.28, ns P = 0.1236; t ∆miR-137-miR137-Syt1 = 1.03, ns P = 0.7317; t ∆miR-137-∆miR137-Syt1 = −0.93, ns P = 0.789; t miR-137-∆miR137-Syt1 = 1.37, ns P = 0.5278; t miR-137-Syt1-∆miR137-Syt1 = −2.07, ns P = 0.1825; n, number of animals. ns, not significant. Error bars, s.e.m. npg a r t I C l e S of Syt1 led to an increase in total number of vesicles as compared to control (Supplementary Fig. 7e ), which was also reflected in more vesicles in the periphery. We also measured frequency facilitation in the mossy fiber-CA3 pathway of miR-137 OE -Syt1-Venus-transduced slices. The amplitude of the synaptic response exceeded ∆miR-137 OE -Venus control levels and stabilized around 500%, similar to that of ∆miR-137 OE -Syt1-Venus. Facilitation in the presence of miR-137 OE -Venus alone was impaired (Fig. 6d) . Surprisingly, LTP induction was restored under the same conditions (Fig. 6e) and baseline synaptic transmission was not altered (Fig. 6f) . When we measured the freezing response using contextual fear conditioning, we found a significant improvement in the memory performance in animals in which Syt1 was restored (miR-137 OE -Syt1-Venus), as compared to those with miR-137 OEVenus or Syt1 alone (Fig. 6g) . Nociception in response to shock was not altered (Supplementary Fig. 7 ). In conclusion, Syt1 by itself did not restore a normal vesicle distribution in the presence of miR-137 OE , although the perturbation in the synaptic vesicle pool, as well as the LTP deficits, were ameliorated by its expression.
It has previously been shown that high frequency stimulationinduced LTP at the mossy fiber-CA3 synapses is independent of presynaptic mechanisms 27 . Since we observed LTP improvement upon Syt1 overexpression, we were interested in whether Syt1 knockdown by its own could affect LTP induction. Consistent with the miR137 OE condition, we observed impairment in LTP induction at the mossy fiber synapse in the presence of Syt1 knockdown ( Supplementary  Fig. 8 ). When we measured baseline synaptic transmission, we found a decrease in synaptic strength. Frequency facilitation measurements showed a decrease in the field excitatory postsynaptic potential (fEPSP) slope in the presence of Syt1 knockdown ( Supplementary  Fig. 8 ). These data suggest that Syt1 loss of function results in synaptic dysfunction at mossy fiber synapses, which likely mimics the miR-137 OE phenotype.
DISCUSSION
In this study, we investigated the functional impact of psychiatric risk SNPs in MIR137. We observed an upregulation of endogenous MIR137 in induced human neurons harboring the minor alleles of four schizophrenia-associated SNPs in the putative MIR137 region. This raised the question of what the mechanistic consequences are of MIR137 gain of function. We were intrigued to find among the predicted miR-137 targets multiple candidate genes with known presynaptic function. Since the role of microRNAs at the presynapse has been unexplored, we were interested in determining whether miR-137 could be a regulator of presynaptic function.
We found that Cplx1, Nsf and Syt1 were directly regulated by miR-137 expression: upregulation of miR-137 caused a decrease in their protein levels (Fig. 2e) and vice versa (Fig. 5d) . Remarkably, those target genes are consistently found to be downregulated in the postmortem brains of schizophrenia patients [28] [29] [30] [31] [32] . Syn3, on the other hand, remained low even when endogenous miR-137 was sequestered, which suggests that additional endogenous factors modulate Syn3 levels. Further exploration of the role of miR-137 at the presynapse showed that miR-137 gain of function reduced vesicle release in induced neurons. In support of these findings, in vivo experiments showed alterations in the synaptic vesicle pool, reduced frequency facilitation and LTP induction, as well as impairment in hippocampus-dependent learning.
We also provide evidence that Syt1 is an important component in inducing mossy fiber LTP 27 . Mossy fiber LTP has been shown to be NMDA receptor independent and is likely to be induced via presynaptic mechanism. Rab3a and RIM1α are two presynaptic proteins that have been shown to be involved in LTP induction at these synapses 33, 34 . By Syt1 knockdown alone and in combination with miR-137 OE , we have identified a new mechanism mediating mossy fiber LTP.
Previous studies have shown that loss of Cplx1, Syt1 or both impairs Ca 2+ -triggered evoked neurotransmitter release independent of species and synapse type 26, [35] [36] [37] [38] . Syt1 and Nsf were reported to be involved in vesicle recycling [39] [40] [41] . Synaptic vesicles are depleted in synaptotagmin mutants of Caenorhabditis elegans, and hypomorphic mutation of Nsf in Drosophila melanogaster has been shown to cause paralysis within a couple of minutes, after the functional vesicle pool is exhausted. Syn3 can influence recycling and recruitment of vesicles 42, 43 , and Syn3 knockdown increases the number of synaptic vesicles in the reserve pool 44 . Nonetheless, these previous studies only knocked down one gene of interest and not a set of genes, as we have done with the microRNA overexpression approach. Thus, microRNAs could open a new way of studying closely intermingled presynaptic pathways. However, we analyzed only a subset of predicted miR-137 target genes at the presynapse. We cannot exclude the possibility that other miR-137 targets might also act at the presynapse. Furthermore, the relative abundance of mRNAs in a cell can affect microRNA efficiency.
Despite the effect of miR-137 on multiple mRNAs, we attempted to rescue synaptic function by coexpressing a miR-137-insensitive Syt1 transcript. As predicted, restoration of Syt1 rescued some but not all of the miR-137 OE phenotypes. Moreover these rescued phenotypes were distinct from those of Syt1 overexpression alone. For example, vesicle distribution was not fully restored. This suggests that reductions in Cplx1 levels, even with Syt1 restoration, may hinder vesicle recruitment to the active release site, allowing the phenotype of impaired vesicle release to persist in the presence of miR-137 gain of function. Whether a simultaneous restoration of Cplx1 and Syt1 under miR-137-mediated downregulation would rescue the phenotype remains to be determined. Additionally, other, not yet identified miR-137 targets may be involved. For example, Bacaj et al. 26 recently showed that, while Syt1 is important for fast, synchronous vesicle release, the related protein Syt7 is necessary for slow, asynchronous release. Therefore, additional factors such as Syt7, itself a potential miR-137 target (Supplementary Fig. 2 ), could influence this phenotype.
In previous studies, miR-137 has been associated with adult neurogenesis and alteration in dendritic branching 7, 9 . Consistent with these findings, we observed increased adult neurogenesis in the presence of miR-137 OE (Supplementary Fig. 8 ). miR-137 overexpression in adult neuronal stem cells leads to delay in maturation of these neurons 7, 9 . In future studies, it will be of interest to determine how alterations in neural stem cell proliferation and maturation affect learning and memory following miR-137 overexpression. We also note that we observed normal LTP at medial perforant path-dentate gyrus synapses, suggesting that the impaired mossy fiber LTP is not caused by alteration of the input to the dentate gyrus (Supplementary Fig. 8 ).
Schizophrenia has long been proposed to be "a disease of the synapse" [45] [46] [47] , with the underlying assumption that synaptic malfunction can severely affect brain connectivity 16 . Several studies describe changes in the expression of genes functionally implicated in both pre-or postsynaptic mechanisms in schizophrenia patients 32, 48, 49 . Wen et al. 49 have proposed a model in which large-scale transcriptional dysregulation in human neurons harboring alterations in disrupted in schizophrenia 1 (DISC1) could affect synaptic function and lead to major psychiatric disorders. Here we provide a model in which a single regulatory microRNA can simultaneously control npg a r t I C l e S several protein targets, thus regulating an entire pathway resulting in synaptic alterations. This mechanism might lead to new treatment strategies for diseases such as schizophrenia.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Animals.
Animal experiments were approved by the MIT Committee on Animal Care (CAC). Mice were housed in groups of 3-5 animals in a 12 h light/12 h dark cycle, with standard mouse chow and water ad libitum. If not otherwise indicated, at least 2-month-old male C57BL/6 mice from Jackson Laboratory were used for all experiments. Mice that received bilateral stereotactic injection into the dorsal dentate gyrus with a lentivirus are labeled as follows: "miR-137 OE " and "∆miR-137 OE " for miR-137 overexpression and control, respectively; "Sponge miR-137 " and "Sponge Control " for the sponge-mediated sequestration of endogenous miR-137 and control, respectively; "∆miR-137 OE -Venus", "miR-137 OE -Venus", "miR-137 OE -Syt1-Venus" and "∆miR-137 OE -Syt1-Venus" for miR-137 control, miR-137 overexpression, overexpression of miR-137 and synaptotagmin-1, and miR-137 control and synaptotagmin-1, respectively; "Syt1-KD" and "Syt1-KD Control " for knockdown of Syt1 only and control, respectively 37 . For the endogenous experiments in Figure 2d and Supplementary Figure 7a Human fibroblasts. Human fibroblasts were obtained from the Coriell Institute, McLean Hospital, the Massachusetts General Hospital and the American Type Culture Collection (ATCC). We selected the human fibroblasts on the basis of four disease-associated SNPs in the MIR137 locus. There is a chance that other SNPs, further away from the gene locus, could influence miR-137 expression; however, we chose to genotype cells for SNPs that are both close to the MIR137 locus and significant GWAS hits. Also, two of these SNPs affect transcriptional activity (Supplementary Fig. 1 ). Four lines were homozygous for the major allele and two lines for the minor allele at all four SNPs, where by definition the major allele is the more common allele in the population and the minor allele the less prevalent. Human fibroblasts were cultured in D15 medium (DMEM with sodium pyruvate containing GlutaMax (Invitrogen), 15% (v/v) FBS and penicillin/streptomycin at 37 °C and 5% CO 2 .
genotyping protocol for disease-associated SnPs in human fibroblasts. Genomic DNA from human fibroblasts was prepared using the DNeasy Blood & Tissue Kit (Qiagen). An approximately 1,000-bp fragment was amplified using the PhusionMasterMix according to the manufacturer's directions (New England Biolabs; Supplementary table 1). The PCR product was purified with NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel), then subjected to Sanger sequencing. direct reprogramming of human fibroblasts into induced neurons. Constructs: Human ASCL1, POU3F2 (also known as BRN2) and MYT1L cDNAs were separately cloned into the lentiviral vector pHRST-IRES-GFP, which contains an IRES-EGFP cassette under the control of a CMV promoter. The lentivirus envelope plasmid pMD.2G-VSV G and the packaging plasmid pCMVdeltaR8.2 were purchased from Addgene (plasmids 12259 and 12263, respectively) 50 . Lentivirus was generated for all three human plasmids as described below. The reprogramming efficiency of the different fibroblast lines should be independent of the age and sex of the patient 51 .
Induction: One day before virus transduction, human fibroblasts were plated at a density of 7.5 × 10 5 cells per dish in 60-mm dishes in D15 medium with no antibiotics. The next day, 25 µL of each lentivirus containing human ASCL1, BRN2 and MYT1L were combined in D15 medium supplemented with 2.5 µL of 8 mg/mL Polybrene (Sigma-Aldrich). The medium was changed 8-16 h after transduction. The following day the medium was changed to N3 Induced Neuron Medium (DMEM/F12) containing GlutaMax (Invitrogen), 25 µg/mL insulin, 30 nM sodium selenite, 20 nM progesterone, 100 nM putrescine (all from SigmaAldrich), 50 µg/mL transferrin (Roche) and 10 ng/mL bFGF (R&D Systems). The N3 medium was changed every 3-5 d for 4 weeks. To isolate induced neurons for qRT-PCR, we used herpes simplex virus (HSV; MIT Viral Core) expressing mCherry under the control of the CAMK2A promoter (HSV-CK-mCherry). The CAMK2A promoter drives expression in glutamatergic excitatory neurons in the hippocampus and cortex 52, 53 . Two days after transduction with the HSV-CK-mCherry virus, cells were treated with Accutase (5 min at 25 °C) and resuspended in icecold FACS buffer (HBSS containing B27, 20 mM glucose, penicillin/streptomycin, 1 mM EDTA). Cultures were then centrifuged for 10 min at 300g at 4 °C and the supernatant was discarded. Cells were resuspended in cold FACS buffer and subjected to fluorescence-activated cell sorting (FACS). Cells positive for mCherry fluorescence were sorted into binding buffer provided by the PureLink miRNA isolation kit (Invitrogen) and processed as described below. The neuronal population ranged between 0.01 and 0.001% of all sorted FACS events.
constructs. Cloning of miR-137 OE and ∆miR-137 OE . For viral expression of human miR-137, MIR137 was amplified from human genomic DNA using the miR-137_5-BamHI and miR-137_3-BstXI primers (Supplementary  table 1) . The amplified DNA fragment was cloned into the lentivirus vector FH1-UGW-mCherry using the BamHI and BstXI restriction enzyme sites. The H1 promoter drives miR-137 expression.
miR-137 construct lentivirus generation. Confluent (90%) HEK-293T cells were transfected with 8 µg lentivirus plasmid (see above), 4.8 µg VSV-G and 4.8 µg of each of the packaging plasmids pRSV-Rev and pMDLg/pRRE using Lipofectamine 2000 (Life Technologies) according to the manufacturer's protocol. Supernatant was collected 48 h later, centrifuged for 5 min at 300g, sterilefiltered through a 0.45 µm filter, then centrifuged at 19,500 r.p.m. for 2 h at 4 °C (Optima I-90K ultracentrifuge, SW41 Ti rotor). The supernatant was discarded and the pellet resuspended in 20 µL cold Dulbecco's phosphate-buffered saline (DPBS, Life Technologies) overnight at 4 °C, then aliquoted and stored at −80 °C. The viral titer was estimated with the Lentivirus qPCR Titer kit (ABM Inc) and typically ranged between 9 × 10 6 and 3 × 10 7 viral units/mL.
FUchW-Syt1-T2A-Venus. Primers were designed to synaptotagmin-1 cDNA (NM_001252342.1) and extended by a BamHI site at the 5′ end and an AsiSI site at the 3′ end (Supplementary table 1) . Syt1 was amplified using the Phusion MasterMix PCR protocol (NEB). The vector FUchW H2KK-T2A-Venus, which contains the T2A cleavage peptide sequence, and the Syt1 PCR amplicon were digested with BamHI and AsiSI, gel-purified, ligated by Quick Ligation Protocol (NEB) and transformed in NEB 10-beta competent cells. Clones were picked, QuickLyse miniprep (Qiagen) performed and the plasmid sequenced. A positive clone was retransformed into Stable-3 cells and plasmid purified with PureLink HiPure Plasmid DNA Purification kit (Invitrogen).
miR-137 OE -Syt1-Venus and ∆miR-137 OE -Syt1-Venus. The vectors miR137-FH1-UGW-mCherry and ∆miR-137-FH1-UGW-mCherry were digested with PspXI and XcmI. The ubiquitin-Syt1-T2a-Venus cassette was digested from the FUchW-Syt1-T2A-Venus using PacI and EcoRI. Both vector and insert were blunted by T4 DNA polymerase (NEB), gel-purified, ligated and transformed as described above.
Primary cortical hippocampal neuronal culture. Primary neurons were prepared as described in ref. 54 . We used embryonic day 16 embryos from timed-pregnant Swiss-Webster mice. Primary neurons cultures were used for experiments at 14 days in vitro.
Stereotactic injection. Stereotactic injections into the dentate gyrus of adult mice were performed as described 55 with the following modifications: 8-week-old C57BL/6 mice were bilaterally injected with 1 µL lentivirus mixed with 0.2 µL fast green dye. Before loading the virus into a glass micropipette (Drummond Wiretrol 10 µL), the inside was coated with mineral oil. The stereotactic coordinates for dorsal dentate gyrus injection were anterior/posterior: −2, medial/ lateral: 1.6, dorsal/ventral: −1.65. The total injection volume was 1 µL, injected at a rate of 0.125 µL/min. Overexpression of miR-137 was detectable at least 4 weeks after injection as quantified by qRT-PCR and by mCherry immunoreactivity (data not shown).
BrdU labeling. We stereotactically injected the lentivirus for miR-137 OE and ∆miR-137 OE as described above. After 1 week of incubation, we injected daily 50 mg/kg of BrdU for 7 d. Animals were then sacrificed and perfused with 4% (w/v) PFA in PBS. The brain was dissected and postfixed overnight. Vibratome sections were prepared and treated with 4 N HCl for 2 h at 25 °C. The slices were washed at least three times with PBS and stained for BrdU and RFP as described below. Images were taken and the numbers of BrdU and RFP-positive cells were counted in a blinded manner.
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Behavior experiments. Mice were housed in groups of 3-5 animals. The behavioral experiments were performed at least 2 months after virus injection. Mice were left to acclimate in the behavior testing rooms for 45-60 min before the experiments. 70% ethanol was used to clean the experimental areas before the tests and between subjects. If the same groups of mice were used in different behavioral experiments, the tests were separated by 1 week. All experiments were done during the light phase, in the second half of the day, with experimenters who were blind to the type of virus injected in the mice. The mice were consistently handled by the base of their tails and transported to the behavioral testing facility by experimenters. Data analysis was performed in a blinded manner.
Contextual and cued fear conditioning. During contextual fear conditioning, mice were placed in a conditioning chamber with Plexiglas walls and a metal grid bottom (TSE fear conditioning system, TSE Systems). They were acclimated for 3 min, then foot-shocked (2 s, 0.8 mA constant current) and returned to their home cages. After 24 h, mice were returned to the same chamber and freezing bouts, defined as a total lack of movement except for heartbeat and respiration, were scored every 10 s during a 3 min period. For cued fear conditioning, animals were placed in the test chamber for 3 min followed by exposure to the auditory cue (30 s, 20 kHz, 75 dB sound pressure level) and a foot shock (2 s, 0.8 mA, constant current) and returned to the home cages. Associative learning was assessed 24 h later by placing the mice into a modified chamber (visual, tactile and olfactory changes), delivering the identical auditory cue for 3 min and recording freezing behavior. For measuring the freezing response before cue, we recorded the number of freezing responses for 30 s after the animal was put in the chamber.
Hot plate analgesia test. Animal was placed on a 55 °C plate. The latency to respond with a nociceptive response (rear paw licking) was measured (hot plate analgesia test meter, IITC Life Sciences Inc., CA).
Morris water maze. Spatial reference memory testing 56 was performed in a circular tank (diameter 1.2 m) filled with opacified water at 22 °C. The walls surrounding the tank had bright and contrasting shapes as reference cues. The tank contained a fixed platform (10 cm diameter) in a target quadrant. On day 1 of the experiment (pre-training), mice were placed in the water, guided toward a visible platform and kept on the platform for 15 s. This procedure was repeated one more time. On the following days, the platform was submerged and the mice were placed into the maze at one of four points randomly facing the wall of the tank to avoid the development of egocentric strategies. Mice were allowed to search for the platform for 60 s. If they did not find the platform, they were gently guided to it. Two trials a day were conducted with 2-min intertrial intervals. Between trials, mice were warmed on a heating pad. Mouse behavior was video-recorded and analyzed using Videomot 2 software (TSE Systems). The escape latency was scored for each trial. For the probe trial, 24 h after the final training day the platform was removed and the time spent in each of the four quadrants (target, opposite, left and right) was recorded. Thigmotaxis was measured by the software.
Open field. All experimental mice were habituated in the open field arena (40 × 40 cm Plexiglas VersaMax chambers, Accusan Instruments) for 30 min, 1 d before the test. To test, mice were placed in the center of the arena and allowed to explore the apparatus for 40 min. During the session, the number of beam breaks was measured automatically.
Light-dark exploration test. The apparatus used for the light/dark test consisted of a cage (41 × 41 × 30 cm) divided into two sections of equal size by a partition with door. Mice were placed into the dark side and the door opened 10 s afterward. Mice were allowed to move freely between the two chambers for 10 min and the whole process was video-recorded. Measurements were taken of the total number of transitions between the light and dark chambers and the total amount of time spent in the light chamber by an observer blinded to experimental condition.
Elevated plus-maze. The maze consisted of a central platform (10 × 10 cm), elevated 50 cm from the floor, with two opposing open arms (30 × 10 × 0.5 cm) and two arms enclosed by dark Plexiglas walls (30 × 10 × 30 cm). Experiments were conducted in a brightly and homogenously illuminated room, with the maze placed in the center of the room. Mice were placed in the intersection of the four arms of the elevated plus maze with the head directed toward a closed arm. The position of the animals was automatically determined and recorded for 5 min with VersaMax software (TSE systems). A test trial using a practice animal was performed before sessions with the experimental mice to make sure the recording system and test conditions were consistent across all animals.
Social interaction test.
A three-chamber social interaction test 57 was performed as in ref. 58 with minor modifications. Specifically, mice were removed from the colony and acclimated to the testing room for 1 h. The mouse designated as the test mouse was placed in the center chamber of the apparatus for a 10-min habituation, with the doors open on each side so that the mouse could explore all three chambers of the apparatus. After 10 min, the doors were closed to contain the mouse in the center chamber. A novel stimulus mouse was placed in one of the side chambers. The choice of adjacent chamber holding the stimulus mouse was randomly determined. The stimulus mouse was enclosed in a small circular wire cage (11 cm in height, 10.5 bottom diameter, bars spaced 1 cm apart). Thus, the stimulus mouse could provide visual, olfactory, auditory and some physical contact cues. An identical empty wire cage was placed in the other adjacent chamber. After that, the doors were opened and the test mouse was set free to examine the entire apparatus, including the stimulus mouse and the empty wire cage. The behavior of the test mouse was videotaped for a 10-min period for later scoring by an observer blind to experimental condition. The time in each compartment, as well as in close proximity to the stimulus mouse, was assessed from the videos. To evaluate a preference for social novelty, the original stimulus mouse remained in the wire cage and a second, novel stimulus mouse was placed in the wire cage in the opposite compartment. The test mouse was placed in the middle compartment and given a further 10 min to explore both of these stimulus mice. The behavior of the test mouse was recorded on video for this 10-min period for later scoring, as in the first part of the experiment.
electrophysiology. Acute hippocampal slice preparation. Lentivirus-injected C57BL/6 mice (3-4 months old) were anesthetized with isoflurane and decapitated. The experimenter was blinded to which virus was injected. Transverse hippocampal slices (400 µm thick) were prepared in ice-cold dissection buffer (in mM: 211 sucrose, 3.3 KCl, 1.3 NaH 2 PO 4 , 0.5 CaCl 2 , 10 MgCl 2 , 26 NaHCO 3 and 11 glucose) using a Leica VT1000S vibratome (Leica). Slices were recovered in a submerged chamber with 95% O 2 /5% CO 2 -saturated artificial cerebrospinal fluid (ACSF) consisting of (in mM) 124 NaCl, 3.3 KCl, 1.3 NaH 2 PO 4 , 2.5 CaCl 2 , 1.5 MgCl 2 , 26 NaHCO 3 and 11 glucose for 1 h at 28-30 °C. All recorded slices were subjected to immunohistochemistry with antibodies against mCherry to ensure that an equivalent number of virus-transduced cells were present in each slice.
Extracellular recordings. A tungsten bipolar electrode was placed in the dentate granule cell layer to stimulate mossy fibers, and extracellular recordings were made in the stratum lucidum of CA3 using a glass microelectrode filled with ACSF (resistance of 2-3 MΩ). Frequency facilitation was elicited by lowfrequency (1 Hz) stimulation for 30 s. For mossy fiber LTP recordings, three trains of high frequency stimulation (100 Hz for 1 s) were delivered at 20-s intervals after observation of a stable baseline. To verify mossy fiber inputs, 1 µM (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine (DCG-IV; Tocris Bioscience), a group II metabotropic glutamate receptor agonist that selectively blocks mossy fiber responses, was applied at the end of each recording. The amplitudes of fEPSPs were measured to quantify the strength of synaptic transmission. An AM-1800 microelectrode amplifier (A-M systems) and a Digidata 1440A A-D converter (Axon Instruments) were used for data acquisition and data were analyzed with pClamp10 (Axon Instruments). The input-output curve was obtained by plotting the amplitude of fEPSPs against fiber volley amplitudes.
For the perforant path recording, we stimulated the medial perforant path and recorded fEPSPs in the molecular layer of the dentate gyrus as described previously 59, 60 . To distinguish whether the medial or lateral perforant path was stimulated, we measured the synaptic response to paired pulses given 50 ms apart 61 . LTP was induced by 4× HFS protocol (100 Hz for 0.5 s at 20 s intervals) 60 in the presence of picrotoxin (100 µM) to reduce GABAergic inhibition. The input-output relationship was estimated by plotting the fEPSPs slope against the stimulation intensity.
Immunohistochemistry. After electrophysiological recording, slices were fixed in 4% (wt/vol) paraformaldehyde in PBS overnight at 4 °C, washed in PBS several times, then transferred to 30% (wt/vol) sucrose in PBS and incubated overnight at 4 °C for cryoprotection. To increase antibody permeability, the slices were put on a glass slide, frozen on the coverslip over dry ice and thawed at room temperature for three cycles. Then the slices were transferred to PBS, washed for 10 min at 25 °C and blocked in 5% (vol/vol) normal donkey serum (NDS, Sigma), 0.3% together with the positive control assay (qHsaCtlD0001003) according to the manufacturer's protocol (Bio-Rad Laboratories).
Analysis. Analysis was performed using the ∆∆CT method with β-actin (Actb) as the calibrator gene 68 . Primer sequences were as follows: Actb (GGGAAATCGTGCGTGACATT, GGGAAATCGTGCGTGACATT), Cplx1 (GGAAGATGCTTGGGGGTGAT, GGAAGATGCTTGGGGGTGAT), Nsf (GATCGGCGGTCTGGATAAGG, GATCGGCGGTCTGGATAAGG), Syn3 (CTCGCATTCAGCATCTTGCC, CATACTGGAGGCCGATGACC), Syt1 (AAGTCCACCGGAAAACCCTC, AAGTCCACCGGAAAACCCTC). miR-137 mimic experiment. One day before transfection, 60,000 N2a or HT22 cells were seeded per well of a 12-well plate. Transfection was performed with Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. 20 µM miRIDIAN Mimic mmu-miR-137 (Dharmacon) and 0.5 µg/µL control plasmid expressing GFP were transfected. 48 h later, RNA was isolated and qRT-PCR performed.
western blot. Tissue preparation. Fluorescent cells in the dentate gyrus-CA3 were dissected under a stereo fluorescence microscope (Olympus, SZX16) and snap-frozen in liquid nitrogen.
Synaptosome preparation. 500 µL ice-cold homogenization buffer (10 mM HEPES pH 7.4, 2 mM EDTA, 2 mM EGTA, 320 mM sucrose supplemented with one PhosphoSTOP tablet, Roche) was added, and the brain samples were homogenized with a 26G needle and syringe on ice. For the input sample, 150 µL was set aside, supplemented with 1% (w/v) SDS (final concentration) and boiled at 95 °C for 5 min. The rest of the sample was centrifuged for 10 min at 800g at 4 °C to remove nuclei and cell debris. The supernatant was then recentrifuged at 12,000g for 15 min at 4 °C to enrich for synaptic components. The pellet was resuspended in 60 µL 1% (w/v) SDS and boiled at 95 °C for 5 min. Protein concentrations were measured with the BCA protein assay kit (Thermo Scientific).
SDS gel. 30-50 µg protein were loaded on a 4-15% mini protean TGX SDSgradient gel (Bio-Rad Laboratories) together with Precision Plus protein prestained standard dual color (Bio-Rad Laboratories) ladder and run at 200 V for 30 min in running buffer (25 mM Tris base, 190 mM glycine, 0.1% (w/v) SDS, pH ~8.3).
Transfer. Protein was transferred to Immobilion PVDF transfer membrane (Millipore) in transfer buffer (25 mM Tris, 192 mM glycine, 20% (vol/vol) methanol) for 1 h at 100 V constant, 350 mA. The membrane was blocked for at least 1 h in 5% (wt/vol) non-fat dry milk in Tris-buffered saline (25 mM Tris, 150 mM NaCl, 2 mM KCl, pH 8.0, 15 mM NaCl, 10 mM Tris, pH 8.0). Primary antibodies rabbit complexin-1 (Proteintech, 10246-2-AP), mouse Nsf-1 (MA1-12435) and rabbit Syn3 (OSS00018W, 1:300) from Thermo Scientific, mouse Syt1 (105 011) from Synaptic Systems and mouse β-actin (A5316) from Sigma-Aldrich were added 1:2,000 in blocking solution and incubated for 2-3 days on a shaker at 4 °C. The membrane was washed 3× for 30 min in Tris-buffered saline and incubated with secondary antibody (1:10,000, Li-Cor: IRDye 680 RD donkey anti-mouse IgG (H+L), 925-68072; IRDye 680RD donkey anti-rabbit IgG (H+L), 925-68073; IRDye 800CW donkey anti-mouse IgG (H+L), 925-32212; IRDye 800 CW donkey anti-rabbit IgG (H+L), 925-32213). Detection was performed using an Odyssey machine (Li-Cor). Image Studio 2.0 software was used for image analysis. The membrane was stripped with NewBlot PVDF 5× stripping buffer (Li-Cor) according to manufacturer's protocol. We normalized and corrected for uneven loading using the intensity of the internal control band, β-actin.
Fm4-64 imaging of human direct induced neurons. We performed the experiments after consolidation of previous methods 69, 70 . Cultures of human direct induced neurons 4-6 weeks old were loaded with 10 µM FM4-64 (Invitrogen) for 2 min in saline solution containing 170 mM NaCl, 3.5 mM KCl, 0.4 mM KH 2 PO 4 , 5 mM NaHCO 3 , 1.2 mM Na 2 SO 4 , 1.2 mM MgCl 2 , 1.3 mM CaCl 2 , 5 mM glucose, 20 mM N-tris(hydroxymethyl)-methyl-2-aminoethane-sulfonic acid, pH 7.4) supplemented with 60 mM KCl. The cells were rinsed with saline solution only and then incubated with 10 µM FM4-64 in saline solution. The cells were washed three times with saline solution for a total of 5 min, followed by a wash for 1 min with 1 mM ADVASEP-7 (Sigma-Aldrich) in saline solution. FM4-64 imaging was performed on an LSM 710 confocal microscope (Zeiss) with a Plan-Apochromat 20×/0.8 objective with images taken every 5 s at 25 °C. A 1-min baseline was recorded, followed by stimulation with 60 mM KCl in saline solution for 4 min. Cells were excited at 558 nm and the emission measured at 734 nm. Images were analyzed in a blinded manner in Fiji using the "plot z-axis profile" plug-in. We analyzed potential functional nerve terminals located along the GFP-positive cell (Supplementary Fig. 2) . The FM4-64 signal was determined by F = (F 1 − B 1 )/(F 0 − B 0 ). Signal was normalized to mean fluorescence intensity measured at baseline condition.
Statistical methods. All statistical analysis was performed in RStudio (version 0.98.501) and R (version 3.0.2). All charts show the mean and s.e.m. Each data set was analyzed for its ability to meet the statistical assumptions for equality of the variance, for normal distribution and for sphericity. The effect size r is indicated, where applicable. The assumption of the parametric test was calculated using the Levene test (leveneTest, package car version 2.0-19). If the assumption was met, the following tests were used: Welch two-sample t-test (t, t-test, package, stats version 3.0.2), independent t-test (T y , yuen, package WRS version 0.24), analysis of variance for one or more fitted model objects (F, ANOVA, stats version 3.0.2), multivariate analysis of variance (V, MANOVA, package, stats version 3.0.2, Pillai-Bartlett trace). If the assumption was validated, the following tests were performed: Wilcoxon-rank sum and signed rank tests (W, wilcox.test, package stats version 3.0.2) and Kruskal-Wallis rank sum test (H, kruskalmc, package pgirmess 1.5.8). Post hoc analysis was performed using either pairwise comparisons between group levels (pairwise.t.test, package stats version 3.0.2, Benjamini and Hochberg-adjusted P value for multiple comparisons), multiple comparisons of means: Tukey contrasts (glht, package multcomp version 1.3-2, mcp and "Tukey"), or multiple comparison test following Kruskal-Wallis rank sum test. ns P, not significant, *P < 0.05, **P < 0.01, ***P < 0.001.
Sample size. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications. For biochemical (immunohistochemistry, western blotting) and molecular (qRT-PCR, luciferase) the minimum number of biological replicates needed for non-parametric statistical analysis is three animals per condition, per experiment. To improve our statistical power and ensure that our hypotheses were rigorously tested, we tried to include 4 to 5 biological replicates in each experiment and to replicate each experiment at least once when possible. Behavior and in vivo experiments have a higher inherent variability, and it is customary to include >8 animals to achieve appropriate statistical power. For behavior, these experiments were typically repeated at least once with a separate cohort of animals. The number of animals used for survival surgery was dictated by the subsequent experiments that those animals would be engaged in (behavior, tissue harvesting or both).
A Supplementary methods checklist is available.
